HIV前病毒整合BACH2基因可改变免疫细胞状态并促进病毒持久
HIV genetic remnants can alter immune cells in ways that may promote viral persistence
莱布尼茨病毒研究所研究显示,HIV前病毒整合入BACH2基因可绕过正常调控机制,维持BACH2蛋白高水平表达。这导致CD4+ T细胞生存与增殖能力增强,免疫激活及炎症反应基因活性降低,从而可能促进HIV长期持久。该机制提示抑制前病毒转录活性(如"block and lock"策略)或可限制病毒驱动的免疫调节效应。
HIV may be suppressed by antiretroviral therapy, but its genetic material remains in the body. New research by scientists at the Leibniz Institute of Virology (LIV) in Hamburg suggests that some of these viral remnants may be doing more than simply lingering: Integration of HIV in specific genes, such as the BACH2 master regulator, can change the biology of the cell carrying it. This pushes CD4 T cells towards a state that favors long-term survival, continued division and altered immune activity.
This observation may explain why HIV is able to persist for so long in the bodies of infected people. The study is published in the journal PLOS Pathogens.
Antiretroviral therapy has transformed HIV from a once-deadly infection into a manageable chronic condition. While treatment prevents the virus from multiplying, it cannot remove viral DNA that has already become part of the genome of infected immune cells. In people who have lived with HIV for many years, these so-called proviruses are generally defective and cannot produce new viruses. A large proportion, however, remain transcriptionally active, continuing to produce viral RNA and proteins.
The new study by the BMFTR junior research group "Genomics of Retroviral Infections," led by PD Dr. Dr. Ulrike Lange, shows that these defective proviruses do more than simply generate "background noise"—they can also influence the biology of the cells in which they reside.
In people who have received long-term treatment for HIV, proviruses are frequently found integrated in selected gene hotspots. One of these hotspots is BACH2, a gene that plays an important role in regulating immune-cell development and function. HIV integrations involving BACH2 have been detected in up to 40% of people living with HIV. "We wanted to understand what their presence means for the cells that carry the integration," says Lange.
To investigate, researchers from the Genomics of Retroviral Infections group at LIV recreated an HIV integration site found in people living with HIV. Using the genome-editing technique CRISPR-Cas9, they introduced an HIV sequence into a specific region of the BACH2 gene in CD4 T-like cells.
Defective HIV DNA can change the properties of infected cells
The researchers found that activity of the integrated HIV sequence increased the production of BACH2 protein. Normally, the cell tightly regulates BACH2 through feedback mechanisms. But in the presence of the integrated HIV sequence, these controls were bypassed, leading to maintenance of unusually high levels of BACH2 and widespread changes in gene activity.
"Modeling these effects in primary T cells, we found that genes involved in immune activation and inflammatory responses became less active in affected cells. At the same time, genes associated with the maintenance and survival of long-lived T cells became more active. In agreement, the cells also showed increased proliferation rates," says Lisa Brauckmann, co-first author of the study and Ph.D. student at LIV.
The resulting molecular immune profile closely resembled one previously observed in expanded clones of HIV-infected cells from people living with HIV. "We observed that the integrated HIV sequence can disrupt the normal regulation of BACH2 and push the cell toward a state that favors long-term survival and continued division," says Dr. Martin Hamann, co-first author of the study and postdoctoral researcher at LIV.
"Interestingly, the immune state of the cells was also altered and we found signs that these cells might inhibit innate mechanisms that keep the HIV reservoir in check. Our findings therefore not only offer an explanation for how defective viral sequences can persist for years, but also highlight a mechanism by which these sequences may contribute to altered immune homeostasis that can impact HIV persistence," says Lange.
In view of potential therapeutic applications, the researchers found that reducing transcriptional activity of the integrated HIV sequence diminished the observed changes associated with its presence in the BACH2 gene. These results raise the possibility that suppressing the activity of persistent viral sequences—in line with the proposed "block and lock" strategy for an HIV cure—could, in the future, offer a therapeutic way to limit virus-driven immunomodulatory effects.
Publication details
Martin V. Hamann et al., Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses, PLOS Pathogens (2026). DOI: 10.1371/journal.ppat.1014618
Journal information: PLoS Pathogens
Key medical concepts
Provided by Leibniz Institute of Virology (LIV)
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: HIV genetic remnants can alter immune cells in ways that may promote viral persistence (2026, October 21) retrieved 21 October 2026 from https://medicalxpress.com/news/2026-10-hiv-genetic-remnants-immune-cells.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com